GSE172219 adenosine 3 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE172219_adenosine_3_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE172219_adenosine_3_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE172219_adenosine_3_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE172219_adenosine_3_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

THAP9 antisense RNA 1

Gene

OIP5 antisense RNA 1

Gene

p53 upregulated regulator of p53 levels

Gene

taxilin gamma Y-linked (pseudogene)

Gene

TALAM1 transcript, MALAT1 antisense RNA

Gene

endogenous Bornavirus like nucleoprotein 3, pseudogene

Gene

PCBP1 antisense RNA 1

Gene

PSMA3 antisense RNA 1

Gene

GTPase, very large interferon inducible pseudogene 1

Gene

COX10 divergent transcript

  • Gene

    THAP9 antisense RNA 1


  • Gene

    OIP5 antisense RNA 1


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    TALAM1 transcript, MALAT1 antisense RNA


  • Gene

    endogenous Bornavirus like nucleoprotein 3, pseudogene


  • Gene

    PCBP1 antisense RNA 1


  • Gene

    PSMA3 antisense RNA 1


  • Gene

    GTPase, very large interferon inducible pseudogene 1


  • Gene

    COX10 divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.